AtriCure is pleased to announce the first patients have been treated with our novel dual energy platform that integrates PFA with Advanced RFA. The new platform delivers the benefits of both technologies while decreasing ablation time, building on our innovative EnCompass clamp Isolator® Synergy™ ablation system. This device is available for investigational use only.

Learn more about the latest innovation here: <a href="https://okt.to/b8dUsu&quot; target="_blank">https://okt.to/b8dUsu</a&gt;